You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosus

Citation Tools

Article menu

Download PDFPDF

Childhood lupus
Original research
Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosus

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Karabag Yilmaz E, Agbas A, Canpolat N, et al
Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosus
Lupus Science & Medicine 2024;11:e001268. doi: 10.1136/lupus-2024-001268